Entecavir In-house Spec.

Entecavir is an oral antiviral drug used in the treatment of hepatitis B infection.


Entecavir is a nucleoside analog (more specifically, a guanosine analogue) that inhibits reverse transcription, DNA replication and transcription in the viral replication process. Entecavir is more efficacious than previous agents used to treat hepatitis B (lamivudine and adefovir).


Entecavir was originally approved by the U.S.FDA in March 2005.


USES Entecavir is used to treat chronic hepatitis B. It also helps prevent the hepatitis B virus from multiplying and infecting new liver cells. Entecavir is also indicated for the treatment of chronic hepatitis B in adults with HIV/AIDS infection. However, entecavir is not active against HIV.


Its dosage forms and strengths are SOLUTION and TABLET;  0.05MG/ML,0.5MG,1MG.


General Data:

CAS No.:

142217-69-4, 209216-23-9 (monohydrate)

Molecular Formula:


Molecular Weight:



white to almost white powder

Note: To view the full Generic APIs list, please click here.
       COAs or Orders request, please contact us or fill up the order form on line.
  • Peptides
  • Generic APIs
  • Custom Peptide Synthesis